News Digging > Podcasts > What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease – 5 questions answered aboutlecanemab
What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease – 5 questions answered aboutlecanemab
What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease – 5 questions answered aboutlecanemab,In clinical trials, lecanemab slowed disease progression by 27% and reduced the amount of plaque found in the brains of those with Alzheimer’s disease.

What the FDA’s accelerated approval of a new Alzheimer’s drug could mean for those with the disease – 5 questions answered aboutlecanemab

In clinical trials, lecanemab slowed disease progression by 27% and reduced the amount of plaque found in the brains of those with Alzheimer’s disease.